FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Gonzalgo

Research Profile

Physiology

DNA Methylation

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Occupations

Robotics

Co-author Network

Publications

TOP 3
HANG WANG; Roula Albadine; Mark W Ball; THOMAS GUZZO; Stefan Hinz; Ahmed Magheli; GEORGES NETTO; Mark P Schoenberg; Mark L Gonzalgo
Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder.
Alan E Thong; Mark L Gonzalgo
Learning from our patients: complications and the future of radical cystectomy for bladder cancer.
Daniel L Willis; Bruce J Trock; Michelle Brotzman; Zhaoyong Feng; Mark L Gonzalgo; Li-Ming Su
Comparison of outcomes between pure laparoscopic vs robot-assisted laparoscopic radical prostatectomy: a study of comparative effectiveness based upon validated quality of life outcomes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Gonzalgo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: HANG WANG; Roula Albadine; Mark W Ball; THOMAS GUZZO; Stefan Hinz; Ahmed Magheli; GEORGES NETTO; Mark P Schoenberg; Mark L Gonzalgo
Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder.
Urologic oncology 2012;30(4):428-33.
2012: Alan E Thong; Mark L Gonzalgo
Learning from our patients: complications and the future of radical cystectomy for bladder cancer.
The Journal of urology 2012;187(6):2018.
2012: Daniel L Willis; Bruce J Trock; Michelle Brotzman; Zhaoyong Feng; Mark L Gonzalgo; Li-Ming Su
Comparison of outcomes between pure laparoscopic vs robot-assisted laparoscopic radical prostatectomy: a study of comparative effectiveness based upon validated quality of life outcomes.
BJU international 2012;109(6):898-905.
2012: Roula Albadine; Alcides Chaux; Jonathan I Epstein; Mark L Gonzalgo; Matthew Eric Hyndman; J Y Jeong; Christian P Pavlovich; Shahrazad Saab; Fabio Tavora; GEORGES NETTO
Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic center.
Human pathology 2012;43(2):254-60.
2011: Jen-Jane Liu; Mark L Gonzalgo
Minimally invasive training in urologic oncology.
Archivos españoles de urología 2011;64(9):865-8.
2011: Jonathan Wu; Mark L Gonzalgo
Use of magnetic resonance imaging to accurately detect and stage prostate cancer: the hype and the hope.
The Journal of urology 2011;186(5):1756-7.
2011: Ahmed Magheli; Mark L Gonzalgo; Li-Ming Su; THOMAS GUZZO; George Netto; Elizabeth B Humphreys; Misop Han; Alan W Partin; Christian P Pavlovich
Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching.
BJU international 2011;107(12):1956-62.
2011: Danil V Makarov; Stacy Loeb; Ahmed Magheli; Kevin Zhao; Elizabeth Humphreys; Mark L Gonzalgo; Alan W Partin; Misop Han
Significance of preoperative PSA velocity in men with low serum PSA and normal DRE.
World journal of urology 2011;29(1):11-4.
2011: Jen-Jane Liu; Mark L Gonzalgo
Editorial comment.
The Journal of urology 2011;185(1):35-6.
2010: Luciana Schultz; Roula Albadine; Jessica Hicks; Sana Jadallah; Angelo M DeMarzo; Ying-bei Chen; Matthew E Neilsen; Mark L Gonzalgo; David Sidransky; Mark P Schoenberg; Matthew E Nielsen; GEORGES NETTO
Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy.
Cancer 2010;116(23):5517-26.
2010: Tin C Ngo; J Joy Lee; Mark L Gonzalgo
Renal pseudoaneurysm: an overview.
Nature reviews. Urology 2010;7(11):619-25.
2010: THOMAS GUZZO; Mark L Gonzalgo; Mohamad E Allaf
Laparoscopic retroperitoneal lymph node dissection with therapeutic intent in men with clinical stage I nonseminomatous germ cell tumors.
Journal of endourology / Endourological Society 2010;24(11):1759-63.
2010: Tin C Ngo; Mark L Gonzalgo
Editorial comment.
The Journal of urology 2010;183(5):1750.
2010: Steven L Chang; Mark L Gonzalgo
Editorial comment.
The Journal of urology 2010;183(2):459; discussion 459.
2010: Eddy S Leman; Mark L Gonzalgo
Prognostic features and markers for testicular cancer management.
Indian journal of urology : IJU : journal of the Urological Society of India 2010;26(1):76-81.
2009: S Eggener; Mark L Gonzalgo; O Yossepowitch
Regarding: 'High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series'.
British journal of cancer 2009;101(12):2057-8; author reply 2059.
2009: THOMAS GUZZO; Ahmed Magheli; Trinity J Bivalacqua; Matthew Nielsen; Frank J Attenello; Mark P Schoenberg; Mark L Gonzalgo
Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer.
Urology 2009;74(6):1276-80.
2009: Mark L Gonzalgo
Editorial comment.
The Journal of urology 2009;182(5):2380-1.
2009: Ahmed Magheli; Mark L Gonzalgo
Editorial comment.
The Journal of urology 2009;182(5):2248; discussion 2248-9.
2009: Mark L Gonzalgo
Editorial comment.
The Journal of urology 2009;182(4):1311-2.
2009: Bruce J Trock; Charles C Guo; Mark L Gonzalgo; Ahmed Magheli; Stacy Loeb; Jonathan I Epstein
Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system.
The Journal of urology 2009;182(4):1364-70.
2009: Mark L Gonzalgo; Dipen J Parekh
Words of wisdom. Re: Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004. Hellenthal NJ, Ramirez ML, Evans CP, deVere White RW, Koppie TM.
European urology 2009;56(3):571-2.
2009: Mark L Gonzalgo
Editorial comment.
The Journal of urology 2009;182(3):913.
2009: Steven L Chang; Mark L Gonzalgo
Surgery: laparoscopic prostatectomy: learning curve and cancer control.
Nature reviews. Urology 2009;6(7):361-2.
2009: THOMAS GUZZO; Mark L Gonzalgo
Robotic surgical training of the urologic oncologist.
Urologic oncology 2009;27(2):214-7.
2009: Mark L Gonzalgo
Training the urologic oncologist of the future: where are the challenges?
Urologic oncology 2009;27(2):192.
2009: Trinity J Bivalacqua; Herman S Bagga; Kaustubha Patil; Ahmed Magheli; Janis M Taube; THOMAS GUZZO; Mark L Gonzalgo
Urethral carcinosarcoma from bladder carcinosarcomatous lesions: analysis of clinicopathological features.
The Canadian journal of urology 2009;16(1):4512-5.
2008: THOMAS GUZZO; Craig G Rogers; Chris Y Deng; Trinity J Bivalacqua; Ganesh S Palapattu; Patrick J Bastian; Mario A Eisenberger; Mark P Schoenberg; Mark L Gonzalgo
Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease.
BJU international 2008;102(11):1539-43.
2008: Ahmed Magheli; Soroush Rais-Bahrami; Bruce J Trock; Elizabeth B Humphreys; Alan W Partin; Misop Han; Mark L Gonzalgo
Impact of body mass index on biochemical recurrence rates after radical prostatectomy: an analysis utilizing propensity score matching.
Urology 2008;72(6):1246-51.
2008: Trinity J Bivalacqua; THOMAS GUZZO; Edward M Schaeffer; Milena A Gebska; Hunter C Champion; Arthur L Burnett; Mark L Gonzalgo
Application of Evicel to cavernous nerves of the rat does not influence erectile function in vivo.
Urology 2008;72(5):1169-73.
2008: Mark L Gonzalgo; Nilesh Patil; Li-Ming Su; Vipul R Patel
Minimally invasive surgical approaches and management of prostate cancer.
The Urologic clinics of North America 2008;35(3):489-504, ix.
2008: Ahmed Magheli; Soroush Rais-Bahrami; Bruce J Trock; Elizabeth B Humphreys; Alan W Partin; Misop Han; Mark L Gonzalgo
Prostate specific antigen versus prostate specific antigen density as a prognosticator of pathological characteristics and biochemical recurrence following radical prostatectomy.
The Journal of urology 2008;179(5):1780-4; discussion 1784.
2008: Michael Müntener; Jonathan I Epstein; David J Hernandez; Mark L Gonzalgo; Leslie A Mangold; Elizabeth B Humphreys; Patrick C Walsh; Alan W Partin; Matthew Nielsen
Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy.
European urology 2008;53(4):767-75; discussion 775-6.
2007: Ahmed Magheli; Soroush Rais-Bahrami; Elizabeth B Humphreys; Hugh J Peck; Bruce J Trock; Mark L Gonzalgo
Impact of patient age on biochemical recurrence rates following radical prostatectomy.
The Journal of urology 2007;178(5):1933-7; discussion 1937-8.
2007: Ahmed Magheli; Soroush Rais-Bahrami; H Ballentine Carter; Hugh J Peck; Jonathan I Epstein; Mark L Gonzalgo
Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
The Journal of urology 2007;178(4 Pt 1):1277-80; discussion 1280-1.
2007: Ahmed Magheli; Soroush Rais-Bahrami; Hugh J Peck; Patrick C Walsh; Jonathan I Epstein; Bruce J Trock; Mark L Gonzalgo
Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
The Journal of urology 2007;178(4 Pt 1):1311-5.
2007: Mark L Gonzalgo; H Ballentine Carter
Update on PSA testing.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(7):737-42.
2007: Mark L Gonzalgo; Ram H. Datar; Mark P Schoenberg; Richard J Cote
The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer.
Urologic oncology 2007;25(3):228-35.
2007: Mark L Gonzalgo; Gangning Liang
Methylation-sensitive single-nucleotide primer extension (Ms-SNuPE) for quantitative measurement of DNA methylation.
Nature protocols 2007;2(8):1931-6.
2006: Matthew Nielsen; Mark L Gonzalgo; Mark P Schoenberg; Robert H Getzenberg
Toward critical evaluation of the role(s) of molecular biomarkers in the management of bladder cancer.
World journal of urology 2006;24(5):499-508.
2006: Craig G Rogers; Mark L Gonzalgo; Gai Yan; Patrick J Bastian; David Y Chan; William G Nelson; Christian P Pavlovich
High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection.
The Journal of urology 2006;176(5):2280-4.
2006: Danil V Makarov; Herman S Bagga; Mark L Gonzalgo
Genitourinary myiasis (maggot infestation).
Urology 2006;68(4):889.
2006: Patrick J Bastian; Mark L Gonzalgo; William J Aronson; Martha Kennedy Terris; Christopher J Kane; Christopher L Amling; Joseph C Presti; Leslie A Mangold; Elizabeth B Humphreys; Jonathan I Epstein; Alan W Partin; Stephen J Freedland
Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
Cancer 2006;107(6):1265-72.
2006: Mark L Gonzalgo; Li-Ming Su; Shehzad Basaria
Visual vignette. Adrenal myelolipoma.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2006;12(1):109.
2006: Mark L Gonzalgo; Patrick J Bastian; Leslie A Mangold; Bruce J Trock; Jonathan I Epstein; Patrick C Walsh; Alan W Partin
Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate.
Urology 2006;67(1):115-9.
2006: Manickam Krishnan; Jinha M Park; Feng Cao; Dongxu Wang; Ramasamy Paulmurugan; Jeffrey R Tseng; Mark L Gonzalgo; Sanjiv S Gambhir; Joseph C Wu
Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(1):106-8.
2005: Mark L Gonzalgo; Christian P Pavlovich; Bruce J Trock; Richard E Link; Wendy Sullivan; Li-Ming Su
Classification and trends of perioperative morbidities following laparoscopic radical prostatectomy.
The Journal of urology 2005;174(1):135-9; discussion 139.
2004: Martin G Friedrich; Daniel J Weisenberger; Jonathan C Cheng; Shahin Chandrasoma; Kimberly D Siegmund; Mark L Gonzalgo; Marieta I Toma; Hartwig Huland; Christine Yoo; Yvonne C Tsai; Peter W Nichols; Bernard H Bochner; Peter A Jones; Gangning Liang
Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7457-65.
2004: Mark L Gonzalgo; Srinivasan Yegnasubramanian; Gai Yan; Craig G Rogers; Theresa L Nicol; William G Nelson; Christian P Pavlovich
Molecular profiling and classification of sporadic renal cell carcinoma by quantitative methylation analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(21):7276-83.
2004: Ioannis M Varkarakis; Sam B Bhayani; Mohamad E Allaf; Takeshi Inagaki; Mark L Gonzalgo; Thomas W Jarrett
Laparoscopic-assisted nephrectomy with inferior vena cava tumor thrombectomy: preliminary results.
Urology 2004;64(5):925-9.
2004: Craig G Rogers; Gai Yan; Shan Zha; Mark L Gonzalgo; William B Isaacs; Jun Luo; Angelo M DeMarzo; William G Nelson; Christian P Pavlovich
Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein.
The Journal of urology 2004;172(4 Pt 1):1501-3.
2004: Srinivasan Yegnasubramanian; Jeanne Kowalski; Mark L Gonzalgo; Marianna Zahurak; Steven Piantadosi; Patrick C Walsh; G Steven Bova; Angelo M DeMarzo; William B Isaacs; William G Nelson
Hypermethylation of CpG islands in primary and metastatic human prostate cancer.
Cancer research 2004;64(6):1975-86.
2004: Masashi Nakayama; Mark L Gonzalgo; Srinivasan Yegnasubramanian; Xiaohui Lin; Angelo M DeMarzo; William G Nelson
GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
Journal of cellular biochemistry 2004;91(3):540-52.
2004: Mark L Gonzalgo; Masashi Nakayama; Shing M Lee; Angelo M DeMarzo; William G Nelson
Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis.
Urology 2004;63(2):414-8.
2003: Mark L Gonzalgo; William B Isaacs
Molecular pathways to prostate cancer.
The Journal of urology 2003;170(6 Pt 1):2444-52.
2003: Mark L Gonzalgo; David Y Chan
Endoscopic basket extraction of a urethral foreign body.
Urology 2003;62(2):352.
2003: Mark L Gonzalgo; Michelle Brotzman; Bruce J Trock; Alan M Geringer; Arthur L Burnett; Jonathan P Jarow
Clinical efficacy of sildenafil citrate and predictors of long-term response.
The Journal of urology 2003;170(2 Pt 1):503-6.
2003: Mark L Gonzalgo; Christian P Pavlovich; Shing M Lee; William G Nelson
Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2673-7.
2003: Mark L Gonzalgo; Davi A de Lacerda; Angelo M DeMarzo; David Y Chan
Persistent purulent drainage from the glans penis: atypical presentation of pyoderma gangrenosum.
The Journal of urology 2003;169(5):1793-4.
2003: Mark L Gonzalgo; Patrick C Walsh
Balloon cuffing and management of the entrapped Foley catheter.
Urology 2003;61(4):825-7.
2002: Gangning Liang; Mark L Gonzalgo; Carol Salem; Peter A Jones
Identification of DNA methylation differences during tumorigenesis by methylation-sensitive arbitrarily primed polymerase chain reaction.
Methods (San Diego, Calif.) 2002;27(2):150-5.
2002: Mark L Gonzalgo; Peter A Jones
Quantitative methylation analysis using methylation-sensitive single-nucleotide primer extension (Ms-SNuPE).
Methods (San Diego, Calif.) 2002;27(2):128-33.
2002: Mark L Gonzalgo; Claus F Eisenberger; Shing M Lee; Bruce J Trock; Fray F Marshall; Steven Hortopan; David Sidransky; Mark P Schoenberg
Prognostic significance of preoperative molecular serum analysis in renal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(6):1878-81.
2000: Mark L Gonzalgo; Mark P Schoenberg; Ronald Rodriguez
Biological pathways to bladder carcinogenesis.
Seminars in urologic oncology 2000;18(4):256-63.
1999: CM Bender; Mark L Gonzalgo; Felicidad A Gonzales; Carvell T Nguyen; Keith D Robertson; Peter A Jones
Roles of cell division and gene transcription in the methylation of CpG islands.
Molecular and cellular biology 1999;19(10):6690-8.
1998: M Tsutsumi; Yvonne C Tsai; Mark L Gonzalgo; Peter W Nichols; Peter A Jones
Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer.
Oncogene 1998;17(23):3021-7.
1998: Mark L Gonzalgo; T Hayashida; CM Bender; Maryland Pao; Yvonne C Tsai; Felicidad A Gonzales; H D Nguyen; TT Nguyen; Peter A Jones
The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines.
Cancer research 1998;58(6):1245-52.
1998: Peter A Jones; Mark L Gonzalgo; M Tsutsumi; CM Bender
DNA methylation in bladder cancer.
European urology 1998;33 Suppl 4():7-8.
1997: Mark L Gonzalgo; CM Bender; E H You; JM Glendening; JF Flores; Graeme J Walker; Nicholas K Hayward; Peter A Jones; JW Fountain
Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors.
Cancer research 1997;57(23):5336-47.
1997: Mark L Gonzalgo; Peter A Jones
Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE).
Nucleic acids research 1997;25(12):2529-31.
1997: Mark L Gonzalgo; Peter A Jones
Mutagenic and epigenetic effects of DNA methylation.
Mutation research 1997;386(2):107-18.
1997: Peter A Jones; Mark L Gonzalgo
Altered DNA methylation and genome instability: a new pathway to cancer?
Proceedings of the National Academy of Sciences of the United States of America 1997;94(6):2103-5.
1997: Mark L Gonzalgo; Gangning Liang; Charles H. Spruck; J M Zingg; W M Rideout; Peter A Jones
Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR.
Cancer research 1997;57(4):594-9.
1996: A R Simoneau; Charles H. Spruck; M Gonzalez-Zulueta; Mark L Gonzalgo; M F Chan; Yvonne C Tsai; M Dean; Kenneth Steven; T Horn; Peter A Jones
Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Cancer research 1996;56(21):5039-43.
1996: A S Yang; Mark L Gonzalgo; Jean-Marc Zingg; R P Millar; J D Buckley; Peter A Jones
The rate of CpG mutation in Alu repetitive elements within the p53 tumor suppressor gene in the primate germline.
Journal of molecular biology 1996;258(2):240-50.
1995: M Gonzalez-Zulueta; A Shibata; P F Ohneseit; Charles H. Spruck; C Busch; M Shamaa; Mahmoud El-Baz; Peter W Nichols; Mark L Gonzalgo; M ] Elbaz M [corrected to El-Baz
High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
Journal of the National Cancer Institute 1995;87(18):1383-93.